Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Biology, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.
Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Cell Stem Cell. 2019 Aug 1;25(2):273-289.e5. doi: 10.1016/j.stem.2019.07.007.
Human monogenic diabetes, caused by mutations in genes involved in beta cell development and function, has been a challenge to study because multiple mouse models have not fully recapitulated the human disease. Here, we use genome edited human embryonic stem cells to understand the most common form of monogenic diabetes, MODY3, caused by mutations in the transcription factor HNF1A. We found that HNF1A is necessary to repress an alpha cell gene expression signature, maintain endocrine cell function, and regulate cellular metabolism. In addition, we identified the human-specific long non-coding RNA, LINKA, as an HNF1A target necessary for normal mitochondrial respiration. These findings provide a possible explanation for the species difference in disease phenotypes observed with HNF1A mutations and offer mechanistic insights into how the HNF1A gene may also influence type 2 diabetes.
人类单基因糖尿病是由参与β细胞发育和功能的基因突变引起的,由于多种小鼠模型未能完全重现人类疾病,因此研究一直具有挑战性。在这里,我们使用基因组编辑的人类胚胎干细胞来了解最常见的单基因糖尿病形式 MODY3,其由转录因子 HNF1A 的突变引起。我们发现 HNF1A 对于抑制α细胞基因表达特征、维持内分泌细胞功能和调节细胞代谢是必需的。此外,我们还鉴定了人类特异性长非编码 RNA LINKA,作为 HNF1A 靶标,对于正常的线粒体呼吸是必需的。这些发现为观察到的 HNF1A 突变引起的疾病表型的种间差异提供了一个可能的解释,并为 HNF1A 基因如何也可能影响 2 型糖尿病提供了机制上的见解。